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Abstract
Background: The aim of this study was to examine the determinants of publication and whether
publication bias occurred in gastroenterological research.
Methods: A random sample of abstracts submitted to DDW, the major GI meeting (1992–1995)
was evaluated. The publication status was determined by database searches, complemented by a
mailed survey to abstract authors. Determinants of publication were examined by Cox
proportional hazards model and multiple logistic regression.
Results: The sample included abstracts on 326 controlled clinical trials (CCT), 336 other clinical
research reports (OCR), and 174 basic science studies (BSS). 392 abstracts (47%) were published
as full papers. Acceptance for presentation at the meeting was a strong predictor of subsequent
publication for all research types (overall, 54% vs. 34%, OR 2.3, 95% CI 1.7 to 3.1). In the
multivariate analysis, multi-center status was found to predict publication (OR 2.8, 95% CI 1.6–4.9).
There was no significant association between direction of study results and subsequent publication.
Studies were less likely to be published in high impact journals if the results were not statistically
significant (OR 0.5, 95 CI 95% 0.3–0.6). The author survey identified lack of time or interest as the
main reason for failure to publish.
Conclusions: Abstracts which were selected for presentation at the DDW are more likely to be
followed by full publications. The statistical significance of the study results was not found to be a
predictor of publication but influences the chances for high impact publication.
Background
Publication bias is the tendency to submit or accept man-
uscripts for publication based on the direction or strength
of the study findings [1]. There are concerns that studies
with statistically significant results are more likely to be
published compared to studies with non significant (neg-
ative) results.
Publication bias is particularly problematic when pooled
analyses are performed as it leads to an overestimation of
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the effect size [2,3]. Therefore, the issue is considered to be
a problem primarily in those areas of research where
meta-analyses are commonly performed [4–6]. Several
studies on the determinants of publication have included
basic science research abstracts [7–11], but so far only one
study has looked into the occurrence of publication bias
in this type of research [12].
There are several methods to detect publication bias in the
medical literature. Most take advantage of the fact that
small studies are more susceptible to publication bias and
may, consequently, show larger treatment effects [13,14].
One of the earliest reports of publication bias in the bio-
medical literature came from the area of hepato-gastroen-
terology. In 1965, T.C. Chalmers et al. examined possible
reasons for the high variability in reported case fatality
rates in post transfusion hepatitis and found an inverse
correlation between sample size and fatality rate [15].
More recently, Shaheen et al. were able to demonstrate
publication bias in the reporting of cancer risk in Barrett's
esophagus by using a funnel plot, a graphical method to
detect publication bias [16]. Preferential publication of
studies with positive results was also shown following the
presentation of abstracts in endoscopy research [17].
Publication bias can arise during several phases of the
publication process [18]. Abstracts submitted to scientific
meetings are at an intermediate stage in the dissemination
of research findings. The Digestive Diseases Week (DDW)
is an important annual event in gastroenterology. The
meeting is jointly organized by the American Gastroenter-
ological Association (AGA), the American Association for
the Study of Liver Diseases (AASLD), the American Society
for Gastrointestinal Endoscopy (ASGE), and the Surgical
Society for the Alimentary Tract (SSAT). Every year, several
thousand abstracts are submitted to this meeting from in-
vestigators worldwide. Approximately half of these ab-
stracts will eventually be followed by full articles in peer
reviewed journals [19]. We wished to study the determi-
nants of publication in gastroenterological research using
DDW abstracts as a representative sample. We were partic-
ularly interested to know whether there is any indication
for publication bias, where this arises and whether it var-
ies by type of research or national origin. We also wished
to survey the abstract authors to determine their percep-
tion as to what factors determined if an abstract went on
to a full publication.
Methods
Study design and sampling
This retrospective cohort study was based on abstracts
submitted to DDW between 1992 to 1995 (n = 17,205).
Each was screened for abstract acceptance status (presen-
tation at a meeting), number of centers participating,
country of origin and research type. The mode of presen-
tation (poster vs. oral) was not known. Multi-center status
was assumed if abstract authors from > 3 different centers
were named. The country of origin was based on the affil-
iation of the first author. Research type was defined as ba-
sic science studies (BSS) if the unit of analysis was not an
intact human. Controlled clinical trials (CCT) were pro-
spective studies on the effects of diagnostic tests or thera-
peutic interventions, using parallel or cross over controls.
"Other clinical research" (OCR) comprised human physi-
ology experiments, epidemiological studies and uncon-
trolled therapeutic studies. The screening was performed
by student raters following a short introduction into re-
search methodology. Following the screening, 50 BSS,
100 OCR and 100 CCT abstracts were randomly selected
from each year using computer assigned random num-
bers, for a total sample size of 1,000
Abstract evaluation
Each abstract in the sample was reviewed in detail as to
study design, sample size and statistical significance of the
study results. Completeness of reporting and details of the
study design were rated and combined into a summary
score of formal abstract quality. The evaluation of ab-
stracts was performed by raters with training in epidemi-
ology and gastroenterology, masked in terms of authors,
origin, acceptance for presentation at the meeting, and
publication status. For all analytical studies (i.e. studies
using designs appropriate for hypothesis testing), results
were considered positive if statistical significance defined
by a p – value < 0.05, or by a 95% confidence interval ex-
cluding unity was achieved for the main outcome of inter-
est, or for the majority of outcomes if these were multiple
[5,20]. Results were considered negative if statistical sig-
nificance was not achieved for the main outcome, or for
the majority of outcomes. Equivocal results were defined
if there were no statements concerning the statistical sig-
nificance of the main outcome, or the majority of out-
comes. Descriptive studies (case reports, case series,
incidence/prevalence studies, qualitative research and de-
scriptions of procedures) were excluded from the main
analyses.
Abstract quality assessment tool
We developed an instrument to evaluate formal abstract
quality based on previously validated quality scoring in-
struments for full papers [21,22]. We also incorporated
into the instrument published guidelines for the prepara-
tion of structured abstracts and short reports [23–25]. De-
pending on the study design, there were up to 21 items,
including, for example, the definition of a research objec-
tive, use of randomization, control for confounding, use
and reporting of adequate statistical methods and appro-
priateness of sample size. A summary score ranging from
0 – 1 could be calculated, adjusting for variations in the
number of applicable items. The development and valida-BMC Medical Research Methodology 2002, 2 http://www.biomedcentral.com/1471-2288/2/7
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tion of this instrument are described in more detail in a
separate article (Timmer, et al. Manuscript submitted for
publication).
Data base searches
Publication status was assessed by searching MEDLINE,
EMBASE, the Cochrane Library (CCT only) and Bios (BSS
only) on the names of first and last authors. Only full
manuscripts in peer reviewed journals as defined by Last
[26] were considered to represent publications. The 1995
scientific impact factor (SIF) of a journal was used as an
approximation of the prestige of a journal. This is a meas-
ure of the frequency with which the "average article" in a
journal has been cited in a particular year or period [27].
Statistical methods
Prior to the examination of publication rates, all continu-
ous data were dichotomized. Sample size medians were
calculated separately for different subgroups (CCT: cross
over, parallel; OCR: physiology, epidemiology, therapy &
diagnostics; BSS: animal studies. More details are present-
ed in a separate publication [28]). Subgroup specific me-
dians were used as cut-off values for high sample size. A
high quality score was defined as a summary score > 0.63
which corresponds to the upper tertile in this sample.
Similarly, high journal impact was defined by an SIF > 3.
Abstracts were categorized into four country groups based
on geopolitical regions: 1) USA/Canada, 2) North and
West Europe (NW Europe), 3) South and East Europe (SE
Europe), 4) other. France and Germany were classified as
NW European, while SE Europe also included Mediterra-
nean countries such as Israel and Turkey. Due to the low
number of submissions from Australia, these were com-
bined with NW-European abstracts. Analyses were re-run
excluding Australian abstracts to examine whether this al-
tered the results.
The major analyses were based on the information de-
rived from the abstract evaluation and the data base
searches. Annual publication rates were calculated using
actuarial survival methods [29]. Adjusted hazard ratios
(HR) for the determinants of publication were calculated
using Cox regression, or by multiple logistic regression if
the assumption of proportional hazards was not met [30].
The independent variables included in the initial model
were: research type, region of origin, sample size category,
quality score category, statistical significance, country
group and multi-center status. The model was reduced us-
ing manual back and forth procedures, with variable se-
lection based on the stability of the effect sizes, and on the
statistical significance of the estimates (p < 0.1).
The association between abstract acceptance and subse-
quent publication was examined separately as the presen-
tation of an abstract was not considered an independent
variable but rather part of the pathway to full publication
(an 'interim outcome'). Logistic regression was used to
predict early publication (< 2 years after the meeting) and
high impact publication within the subgroup of pub-
lished studies.
Sample size considerations
The sample size was chosen to provide sufficient power
(>80%) to detect a 20% difference in publication rates be-
tween studies with statistically non significant ("nega-
tive") results vs. studies with positive outcome. The
calculation allowed for separate analyses for CCT and
OCR, assuming a negative: positive outcome ratio of 1:2,
and a 60% publication rate for positive outcome studies
(= 0.05). Since at the beginning of this study, there were
no data on publication bias following BSS abstract presen-
tations and because of uncertainty about the applicability
of the descriptors used, a higher relevant difference was
chosen for this subgroup (30%) and a smaller sample size
was possible. Statistical significance was assumed on a
95% confidence level (two tailed).
Author survey
A four-page questionnaire was sent to authors of all ab-
stracts, followed, if necessary, by up to two written re-
minders. The final reminder included a short version of
the original questionnaire. The number of publications
identified by the author survey were compared to those
identified by the data base searches to calculate data base
retrieval rates. Responder bias was assessed by comparing
the characteristics of abstracts for which questionnaires
were received with those for which no questionnaires
were received. We corrected for responder bias and incom-
plete retrieval by multiplying the data base derived rate for
the full sample by the reciprocal of the retrieval rate for the
abstracts covered in the survey. Agreement between ab-
stract and survey information was assessed using Cohen's
kappa (κ ) [31].
Models based on the mail survey included, in addition to
those described above, the following: mode of abstract
presentation, governmental funding, funding by industry,
number of previous publications of the principal investi-
gator and age and sex of the investigator.
Results
Abstract characteristics and publication rates
Between 1992 and 1995, 17,205 abstracts were submitted
to DDW (928 CCT, 8028 OCR, 8150 BSS, 99 not classifi-
able (preliminary classification by student raters)). After
revision of the research type by the expert raters, the strat-
ified random sample drawn from these abstracts included
326 CCT, 455 OCR and 219 BSS. Of these, 164 descriptive
studies were excluded from the analysis, reducing the
sample size to 836 (326 CCT, 336 OCR, 174 BSS). Ab-BMC Medical Research Methodology 2002, 2 http://www.biomedcentral.com/1471-2288/2/7
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stract characteristics are shown in Table 1. The highest per-
centage of abstracts with equivocal results was noted in
BSS (overall 40%). OCR and BSS abstracts rarely reported
negative results (12% and 4%, respectively), compared
with CCT (30%). Based on the median sample size, the
following cut off points were used to define large sample
size (total number of abstracts in parentheses): CCT: > 50
subjects for CCT with parallel controls (n = 249), > 15 for
cross over trials (n = 77). OCR: > 30 for therapy/diagnos-
tics (n = 95), > 75 for epidemiological studies (n = 94), >
15 for physiology (n = 147). BSS: animal studies > 9 (n =
90), studies in biological material: not applicable or not
reported (n = 84).
The data base searches were performed three to six years
after abstract submission. For 392 abstracts, full publica-
tions were identified (publication rate 47%, 95% CI 43%
to 50%). In Table 2, publication rates are shown for differ-
ent subgroups. The proportion of published studies was
highest for CCT (52%), lowest for OCR (42%) (BSS: 47%,
p = 0.03 for differences by research type). Accepted ab-
stracts were more often followed by full publication as
compared to abstracts rejected for presentation at the
meeting (58% vs. 32%, p < 0.001). For CCT, multi-center
status, the statistical significance of the study results, and
a high quality score were also associated with higher pub-
lication rates. No differences were found for country of or-
igin or sample size.
Because of the violation of the proportional hazards as-
sumption, Cox regression analysis could not be used to
determine time to publication by research type for the
combined sample. The results of the logistic regression
can be seen in Table 4. Only multi-center status was a sig-
nificant predictor of full publication (OR 2.8, 95% CI 1.6
to 4.9). Type of research, statistical significance of the re-
sults, origin of the abstract and sample size were not asso-
ciated with publication rates. For CCT, multi-center status
(HR 2.0, 95% CI 1.0 – 1.9) and a high quality score (HR
1.4, 95% CI 1.0–1.9) were associated with publication.
No significant predictors of publication for OCR and BSS
were identified. Using the country of the last author as
country of origin, or excluding Australian abstracts from
the analysis did not change the results of any of the mod-
els.
Time to publication and impact factor of the publications
Annual publication rates were highest in the second year
after submission. Of the identified publications, 67%
were published within two years (median time to publica-
tion: 18 months). If a project was not published within
four years, the chances for subsequent publication were
only 3% per year.
The time to publication by research type is presented in
Fig. 1. The proportion of published studies was highest for
CCT at the end of the follow up period, but they took
longer to get published. In contrast, 71% of the BSS pub-
lications appeared within 2 years. This difference by re-
Table 1: Baseline characteristics of abstracts
CCT N (%) OCR N (%) BSS N (%) total N
total sampled 326 455 219 1,000
descriptive studies (excluded) - 119 45 164
total in analysis 326 336 174 836
acceptance of abstract
accepted 227 (70) 214 (64) 101 (58) 542
rejected 99 (30) 122 (36) 73 (42) 294
country region of origin
US/Canada 88 (27) 128 (38) 95 (55) 311
NW-Europe/Australia 138 (42) 107(32) 34 (20) 279
SE-Europe/Mediterranean 52 (16) 44(13) 9(5) 105
other 48 (15) 57(17) 36(21) 141
number of study centers
1–2 280 (86) 324 (96) 173 (99) 777
>3 46 (14) 12 (12) 1(1) 59
statistical significance
positive 140 (43) 149 (44) 65 (37) 354
negative 99 (30) 41 (12) 7(4) 147
equivocal 87 (27) 146 (44) 102 (59) 335BMC Medical Research Methodology 2002, 2 http://www.biomedcentral.com/1471-2288/2/7
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search type was statistically significant (p = 0.01). No
other predictors of rapid publication as defined by publi-
cation within 2 years were identified. Specifically, the sta-
tistical significance of the study results had no influence
on the time to publication in this analysis, neither in the
combined group, nor in any of the subgroups. Among the
392 publications identified by the data base searches,
there were only 15 in languages other than English (4%).
In a multivariate logistic regression model containing all
published studies (n = 392), negative outcomes were less
likely to appear in high impact journals (OR 0.5, 95% CI
0.3–0.6). For equivocal studies, the OR was 1.2 (95% CI
0.7–1.9, reference: positive studies, OR 1.0). Multi-center
status (OR 2.4, 95% CI 1.2–4.9) and a high quality score
(OR 1.7, 95% CI 1.1–2.6) were also retained in this mod-
el, as was the origin (North America: OR 1.0, NW-Europe:
0.9, 95% CI 0.6–1.5, SE Europe: 0.3, 95% CI 0.1–0.6, oth-
er: 0.7, 95% CI 0.4–1.3). The analysis was controlled for
research type which, however, was not itself independent-
ly associated with journal scientific impact. Acceptance for
presentation at a meeting was also associated with publi-
cation in a higher impact journal. The difference was
small but statistically significant (OR for high impact if ac-
cepted: 1.5 (95% CI 1.0–2.4); rejected, OR = 1).
Results of the mail survey
Questionnaires were received for 593 of 1,000 abstracts
(46 returned undeliverable, response rate 62.2%). Of
these, 58 were in short form. Response rates were higher
for authors of subsequently published abstracts (69.9%
vs. 55.6%, based on data base searches, p < 0.001), indi-
cating significant responder bias. The survey identified
387 publications including 306 identified by the data
base searches (data base retrieval rate 79%). The retrieval
rate was lower for manuscripts published in languages
other than English (33%; English language manuscripts:
80%, p = 0.03), however, this group was very small (n =
6). No other factors were associated with retrieval rates.
The combined effect of incomplete retrieval by the data
base searches on the one hand and responder bias in the
survey on the other hand resulted in a significantly higher
publication rate for the survey based analysis as compared
to the data base search (64% vs. 47%). The publication
rate corrected for these biases was estimated to be 58%
(95% CI 55% to 61%).
Where survey information could be validated against in-
formation from the abstracts or from Medline, agreement
was poor (abstract acceptance = 0.5, randomization (CCT
only) = 0.2, statistical significance = 0.3). The poor agree-
ment for statistical significance was due to the large pro-
Table 2: Number of publications and crude publication rates by research type
CCT N (%) OCR N (%) BSS N (%) total N (%)
total in analysis 326 336 174 836
total published 170 (52) 140 (42) 82 (47) 392 (47)
abstract acceptance
accepted 128 (56)* 107(50)* 59 (58)* 292 (54)*
rejected 42 (42) 33 (27) 23 (32) 98 (34)
country group
USA/Canada 43 (49) 57 (45) 48 (51) 147 (48)
N/W Europe/Australia 78 (57) 43 (40) 14 (41) 136(48)
S/E Europe/Mediterranean. 22 (42) 19(43) 6(67) 45 (44)
other 27 (56) 21 (37) 14 (39) 62 (43)
multi-center status
1–3 centers 134(48)* n/a n/a n/a
> 3 centers 36 (78)
sample size
< median 72 (50) 69 (40) 8(44) 142 (43)
> median 98 (54) 68 (42) 12 (41) 181 (48)
statistical significance
positive 84 (60)* 64 (43) 32 (49) 177(50)
negative 47 (48) 17(42) 5(71) 69 (47)
equivocal 39 (45) 59 (40) 45 (44) 144 (43)
quality score
<0.63 103 (47)* 88 (42) 54 (49) 240 (45)
>0.63 67 (63) 52 (41) 28 (44) 150(50)
* p < 0.05 for differences in publication rates between categories. A quality score > 0.63 equals good abstract qualityBMC Medical Research Methodology 2002, 2 http://www.biomedcentral.com/1471-2288/2/7
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portion of abstracts with equivocally reported results. The
majority of these (64%) had become statistically signifi-
cant in the survey (8% negative, 27% equivocal). The date
of publication was missing or incorrect in 58% of the re-
ported publications.
In spite of the evident problems in the reliability and va-
lidity of the survey data, exploratory analysis of the survey
data showed similar trends for the prediction of publica-
tion compared with the data base derived rates (Table 3).
Based on the crude rates, the mode of presentation, the
statistical significance of the results, and the number of
previous publications were found to be significantly asso-
ciated with full publication. There was a trend for higher
publication rates with increasing age of the investigator;
however, this was not statistically significant. Also, this
variable was strongly correlated with the number of previ-
ous publications. Gender differences could not be ade-
quately assessed due to the low number of female
investigators (n = 33). In the multivariate analysis only
the number of previous publications was significantly as-
sociated with publication (Table 4).
Table 3: Survey information and survey based publication rates
CCT N (%) OCR N (%) BSS N (%) total N Publication-rate
total received 192 270 131 593
descriptive studies (excluded) - 67 32 99
total in analysis 192 203 99 4941 66%
presentation at the meeting
oral presentation 44 (24) 27 (14) 22 (22) 93 80%*
poster 120 (65) 128 (66) 65 (66) 313 68%
no presentation 20(11) 28 (20) 11(11) 69 44%
statistical significance of results
positive 126 (66) 136(67) 79 (80) 341 72%*
negative 51 (27) 15(7) 4(4) 70 61%
equivocal 15(8) 52 (26) 16(16) 83 49%
age of principal investigator
< 35 years 12(7) 30(17) 17(20) 49 61%
35–50 years 100(61) 106(60) 43 (51) 249 66%
> 50 years 53 (32) 42 (24) 25 (29) 120 72%
sex of principal investigator
male 145 (93) 156(91) 77 (92) 378 68%
female 11(7) 15(9) 7(8) 33 61%
number of previous publications
up to 10 34(19) 56(31) 33 (33) 154 59%*
>10 149(81) 126 (69) 67 (67) 128 70%
funding2
by industry 106(55) 38(19) 10(10) 154 66%
by government 25(13) 44 (22) 59 (60) 128 73%
*p < 0.05 for differences in publication rates between categories. 1: Totals 494 due to missing values.: 2categories are not mutually exclusive
Table 4: Predictors of publication
data base based 
OR (95% CI)
survey based 
OR (95% CI)
number of applicable abstracts 836 494
abstracts with missing values 0 71
total in analysis 836 423
statistical significance
positive 1 1
negative 0.8(0.6–1.2) 0.7(0.4–1.2)
equivocal 0.7(0.6–1.0) 0.4 (0.2–0.7)
previous publications of PI
less than 10 not available 1
more than 10 1.7(1.1–2.8)
multi-center status
1–3 centers 1 1
> 3 centers 2.8(1.6–4.9) 2.0 (0.9–4.5)
Data base search based: Model 2 17.1, df3, p < .001. Hosmer and 
Lemeshow Goodness-of-FitTest: 2 .24; 3df; p = .97 Survey based: 
Model 2 13.2;df 1; p < .001; Hosmer and Lemeshow: skipped (d.f. <1)BMC Medical Research Methodology 2002, 2 http://www.biomedcentral.com/1471-2288/2/7
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Reasons for non publication
In the majority of the 206 unpublished studies for which
this information was available, the failure to publish rest-
ed with the investigator: 156 projects were never submit-
ted as a manuscript (76% of the unpublished projects).
The most frequent reason for non publication was lack of
time (Table 5). Fifty manuscripts were not published be-
cause of editorial rejection. In addition, 121 manuscripts
were reported to have been rejected at least once before
eventual publication (maximum number of submissions:
5). Reasons for rejection were reported in 22 of the un-
published, and 102 of the eventually published studies,
and most often included methodological problems or
lack of interest in the topic. Negative results were cited as
a reason for rejection in nine cases; however, all nine stud-
ies were eventually published in other journals.
Discussion
This study examine determinants of publication of gas-
trointestinal research, based on a large sample of abstracts
submitted to the major scientific meeting in this field. The
evaluation of the randomly selected abstracts showed a
wide variety in terms of research topic, origin, quality and
research type. Until 1999 all DDW abstracts were pub-
lished as a supplement to Gastroenterology. Abstracts are
often not included in reviews nor are they always easily
available to the interested reader. The reliability of infor-
mation from abstracts has been questioned [32–34]. It is
important to identify the factors which influence full pub-
lication as selective underreporting of research may result
in seriously distorted information [35].
Based on data base searches, approximately about half of
the abstracts were subsequently published as full manu-
scripts. The proportion ranged from 42% for other clinical
research to 52% for controlled clinical trials. This is in ac-
cordance with data reported for other meetings. Publica-
tion rates following abstract presentation have been
published for a large variety of biomedical specialties. In
a recent Cochrane review on publication rates following
abstract presentation, 46 studies were identified, follow-
ing up a total of 15 985 abstracts [36]. Publication rates
varied from 10% to 78%, with a median rate of 47%. This
meta-analysis constitutes an update and extension to a
previous study by Scherer, combining 2391 meeting ab-
stracts from 10 studies, resulting in a pooled publication
rate of 51% [37]. Since the publication of the Cochrane re-
view, more follow up studies were published, including
two in subspecialties of gastroenterology [17,38], two
more studies following up gastroenterological abstracts
are available in abstract form [19,39]. The similarity in the
reporting of publication rates across different meetings is
striking. Only in the report by Eloubeidi, a significantly
lower rate was reported (25%) [17]. We suggest that this
may be due to the restriction to endoscopy research which
may not be representative of more general meetings.
The most important factor found to be associated with full
publication in our study was the acceptance of the abstract
for presentation at the meeting. We found an odds ratio of
2.3 (95% CI 1.7 to 3.1) for publication of accepted ab-
Figure 1
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Table 5: Reasons for non completion or non submission
most important 
factor
other factors
total reporting1 112 112
lack of time 48 (42.9) 76 (67.9)
co-investigator left 12 (10.7) 32 (28.6)
lack of interest 5 (4.5) 25 (22.3)
sample size/recruitment problems 7 (6.3) 26(23.2)
limitations in methodology 4(3.6) 21 (18.7)
unimportant results 3 (2.7) 16(14.3)
rejection anticipated 3 (2.7) 10(8.9)
publication not the aim 3 (2.7) 10(8.9)
negative results 3 (2.7) 11 (9.8)
external problems 6 (5.4) 6 (8.5)
side effects/ethical problems 1 (0.9) 5 (4.5)
equipment/software problems 2(1.8) 3 (2.7)
single decisive factor not reported 15(13.4%) -
1Reasons for rejection were not available from short form question-
naires sent to primary non responders. Multiple responses were 
allowed for "other factors".BMC Medical Research Methodology 2002, 2 http://www.biomedcentral.com/1471-2288/2/7
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stracts, as compared to rejected abstracts. This translates
into a relative risk of 1.6 (95% CI 1.4 to 1.9), a number
which is consistent with data reported by other investiga-
tors [8,39–44]. Scherer calculated a pooled relative risk of
1.8 (95% 1.7 to 2.0) for publication, based on 7 reports
[36]. Generally, the determinants of abstract acceptance
resemble those of subsequent publication, although addi-
tional factors may play a role [42,45]. Acceptance of an
abstract for presentation may influence the decision of au-
thors to pursue full publication. We did not consider ab-
stract acceptance an independent factor in the publication
process, but rather a variable on the causal chain. There-
fore, we did not include this factor in our multivariate
analysis. Our findings on the determinants of abstract ac-
ceptance are reported in more detail in a separate publica-
tion [28].
Most previous studies focused on clinical research, or were
restricted to randomized clinical trials only. Few data are
available on publication processes for basic science. Gen-
erally, due to the higher heterogeneity in terms of study
design and study objectives, results in this group are more
difficult to interpret. However, most trends were similar in
the subanalyses. Basic science research was found to take
less time to publication as compared to clinical research.
This may explain the higher publication rate for BSS as
compared to clinical research which was described by Ki-
roff in a study involving a shorter follow up period, and
was also confirmed in the meta-analysis by Scherer
[12,36]. In our study, the rate and the scientific impact of
publication as measured by the scientific journal impact
factor was similar between basic science research and con-
trolled clinical trials.
A novel aspect was the international context which al-
lowed for the examination of differences in publication
rates based on the origin of the research. In a parallel
study, North American origin was shown to be the most
important predictor of abstract acceptance for presenta-
tion at the US-based DDW-meetings [28]. In contrast, no
difference in the proportion of published studies, nor in
the impact of the publications was found between re-
search from North America or NW Europe and Australia.
There was some indication that abstracts from other coun-
tries than North America, NW Europe and Australia were
of somewhat lower quality, resulting in a lower propor-
tion of high impact publications and lower publication
rates, however, the number of submitted abstracts from
these other countries was low, and estimates were impre-
cise.
Ideally, the decision to submit or accept a manuscript for
publication is based on the scientific quality of the re-
search [1]. This variable is particularly difficult to examine
based on the limited information available from meeting
abstracts. In a study on the fate of emergency medicine ab-
stracts, abstract quality was assessed by a modification of
Chalmers' rating system for the methodological quality of
randomized clinical trials, as well as by a scientific origi-
nality rating [43]. Originality was found to be associated
with subsequent publication, but, as in a previous study
using a similar modification, the methodology score was
not predictive [6,46]. However, only few design features
were included in this score, and the instrument may not
have been very sensitive to differences in formal quality.
In contrast, we used a newly developed 21 item score, en-
compassing various aspects of completeness of reporting
and design features to assess abstract quality. Due to the
wide range of research types and topics within the sample,
originality of the research could not be uniformly as-
sessed. The positive association found for formal quality
and prestige of the publication, however, may be taken as
indicative of a good correlation between form and con-
tent, at least for the subgroup of controlled clinical trials,
as was suspected by other authors [47].
A positive outcome of the study results was not signifi-
cantly associated with subsequent publication. This is
somewhat surprising in view of the consistent findings in
the literature that show an about twofold chance for pub-
lication if the results are statistically significant [36]. One
reason may be the high proportion of equivocal results.
The inability to correctly classify these abstracts is likely to
have diluted the strength of the association studied. Nev-
ertheless, publication bias was still evident from the high-
er impact of publications with positive results, which is is
in accordance with the observation of a higher susceptibil-
ity for publication bias in higher impact journals [4,6]. In
addition, for basic science studies in particular, the low
proportion of positive outcome studies indicated a biased
abstract submission, a phenomenon also demonstrated
by Callaham [43].
Limitations of this study include the low response rate in
the author survey, which compromised the validity of an
analysis based on author information. As significant re-
sponder bias and limitations to the reliability of the infor-
mation given by the surveyed authors were evident, the
results from the survey based models have to be interpret-
ed with caution. On the other hand, the complementary
use of data collection was important to gauge the reliabli-
ty of the information used.
Another limitation stems from the heterogeneity of the re-
search projects and the international context. While this
added valuable information on publication processes in a
wider perspective, a few variables were more difficult to
assess. Lack of comparability between study types may, for
example, explain the failure to show an association be-
tween sample size and full publication. Similarly, nation-BMC Medical Research Methodology 2002, 2 http://www.biomedcentral.com/1471-2288/2/7
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al funding policies are likely to differ considerably, so that
potential effects of source of funding on publication rates
were possibly missed.
Conclusions
Based on the results of our study, there is subtle evidence
for publication bias in gastroenterological research, ex-
pressed by a low proportion of negative outcome abstract
submissions, especially in basic science, and by a lower
proportion of high impact publications if the results are
statistically negative. In the majority of cases, authors are
responsible for the failure to publish. The acceptance of an
abstract for presentation at a scientific meeting seems to
be an important factor in the decision to submit a manu-
script for publication. The submission of studies with sta-
tistically negative results needs to be encouraged,
especially in basic science.
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